Orchestra BioMed

OBIONasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$253.894 M

$4.24 +2.17%

Close of 7 Aug 2026

Revenue

$33.5M

#2865 by revenue

Earnings

-$52.7M

Loss-making

Shares outstanding

58,520,901

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products — ranked by market cap

All 26 →

#12SndlSNDL$320.2M
#13Usana Health SciencesUSNA$285.6M
#14Orchestra BioMedOBIO$253.9M
#15Niagen BioscienceNAGE$246.9M
#16Aurora CannabisACB$185.3M

Where these numbers come from

Share counts and financials for Orchestra BioMed are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.